Medical devices, healthcare technology and the business of care
510(k) clearance · K251592

SteriHub Disinfecting Device and Protective Cover

1World Vista Medical · Decision date Feb 11, 2026

FDA DECISIONK251592

What did the FDA decide?

FDA records K251592 as a 510(k) premarket notification, with a decision dated Feb 11, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Feb 11, 2026

FDA source record

Regulatory record facts

Identifier
K251592
Regulatory pathway
510(k) premarket notification
Product code
QBP
Decision code
SESE
Decision date
Feb 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Cap, Device Disinfectant.

Product code
QBP
FDA device class
2

FDA decision timeline

  1. K251592 received

    Application receipt date recorded by FDA.

  2. K251592 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QBP

Product / regulatory recordCompanyPathwayDecision dateSource
Icu Medical, Inc.510(k) clearanceMar 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

1World Vista Medical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Rio Verde, AZ

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records